Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
Anders Boisen JensenFrida RenströmStefan AczélPatrick FolieMagdalena Biraima-SteinemannFelix BeuschleinStefan BilzPublished in: Obesity surgery (2023)
For patients experiencing weight regain after bariatric surgery, two-thirds of the weight regain can be safely lost with GLP1-RA, providing clinicians with a therapeutic option for this clinical challenge, and highlights the need for a large-scale randomized clinical trial.
Keyphrases
- weight loss
- body mass index
- physical activity
- gastric bypass
- end stage renal disease
- weight gain
- ejection fraction
- newly diagnosed
- chronic kidney disease
- body weight
- rheumatoid arthritis
- bariatric surgery
- roux en y gastric bypass
- palliative care
- clinical trial
- systemic lupus erythematosus
- idiopathic pulmonary fibrosis
- patient reported
- obese patients
- smoking cessation